At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
At the 2019 IAS Meeting, Leonard Calabrese, DO, highlighted the latest advances in basic, translational, and clinical immunology for immune-mediated inflammatory diseases.
Gregory Wu, MD, PhD, from Washington University School of Medicine in St. Louis, answers our questions about his research, which he recently presented at ACTRIMS Forum 2019.
Gregory Wu, MD, PhD, from Washington University School of Medicine in St. Louis, answers our questions about his research, which he recently presented at ACTRIMS Forum 2019.
Gregory Wu, MD, PhD, from Washington University School of Medicine in St. Louis, answers our questions about his research, which he recently presented at ACTRIMS Forum 2019.
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
